Measuring Anatomical Outcomes of Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema With Artificial Intelligence-A Step Toward Individualized Medicine

JAMA Ophthalmol. 2020 Sep 1;138(9):953-954. doi: 10.1001/jamaophthalmol.2020.2464.
No abstract available

Publication types

  • Comment

MeSH terms

  • Artificial Intelligence
  • Deep Learning*
  • Diabetes Mellitus*
  • Diabetic Retinopathy* / drug therapy
  • Humans
  • Macular Edema* / drug therapy
  • Precision Medicine
  • Ranibizumab / therapeutic use
  • Visual Acuity

Substances

  • Ranibizumab